# To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer

> **NCT06039644** · NA · RECRUITING · sponsor: **GenMont Biotech Incorporation** · enrollment: 100 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06039644
- **Lead sponsor:** GenMont Biotech Incorporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-08
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06039644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06039644, "To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06039644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*